Evidence map›Paper›PMID 35704642›Full record

ArticlePloS one2022

Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins.

Sarah A Yunes, Jennifer L S Willoughby, Julian H Kwan, Jessica M Biagi, Niranjana Pokharel, Hang Gyeong Chin, Emily A York, Kuan-Chung Su, Kelly George, Jagesh V Shah and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Sarah A YunesDepartment of Biology, Boston University, Boston, Massachusetts, United States of America.
Jennifer L S WilloughbyProgram in Molecular Biology, Cell Biology, and Biochemistry, Boston University, Boston, Massachusetts, United States of America.
Julian H KwanDepartment of Biochemistry and Center for Network Systems Biology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Jessica M BiagiDepartment of Chemistry and Center for Molecular Discovery, Boston University, Boston, Massachusetts, United States of America.
Niranjana PokharelDepartment of Chemistry and Center for Molecular Discovery, Boston University, Boston, Massachusetts, United States of America.
Hang Gyeong ChinProgram in Molecular Biology, Cell Biology, and Biochemistry, Boston University, Boston, Massachusetts, United States of America.
Emily A YorkDepartment of Chemistry and Center for Molecular Discovery, Boston University, Boston, Massachusetts, United States of America.
Kuan-Chung SuWhitehead Institute for Biomedical Research, Cambridge, Massachusetts, United States of America.
Kelly GeorgeDepartment of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America.
Jagesh V ShahDepartment of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America.
Andrew EmiliDepartment of Biology, Boston University, Boston, Massachusetts, United States of America.
Scott E SchausDepartment of Chemistry and Center for Molecular Discovery, Boston University, Boston, Massachusetts, United States of America.
Ulla HansenDepartment of Biology, Boston University, Boston, Massachusetts, United States of America.ORCID 0000-0001-9803-4185
Boston University · USHarvard University · USWhitehead Institute for Biomedical Research · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
The Design and Implementation of Asymmetric Organocatalysis in SynthesisR01GM078240 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI SCHAUS, SCOTT EDWARD · 2007 to 2018
$2.9M
NCATS NIH HHS UL1 TR001430NIGMS NIH HHS R01 GM078240
6 · The paper itself

Abstract

Factor quinolinone inhibitors (FQIs), a first-in-class set of small molecule inhibitors targeted to the transcription factor LSF (TFCP2), exhibit promising cancer chemotherapeutic properties. FQI1, the initial lead compound identified, unexpectedly induced a concentration-dependent delay in mitotic progression. Here, we show that FQI1 can rapidly and reversibly lead to mitotic arrest, even when added directly to mitotic cells, implying that FQI1-mediated mitotic defects are not transcriptionally based. Furthermore, treatment with FQIs resulted in a striking, concentration-dependent diminishment of spindle microtubules, accompanied by a concentration-dependent increase in multi-aster formation. Aberrant γ-tubulin localization was also observed. These phenotypes suggest that perturbation of spindle microtubules is the primary event leading to the mitotic delays upon FQI1 treatment. Previously, FQIs were shown to specifically inhibit not only LSF DNA-binding activity, which requires LSF oligomerization to tetramers, but also other specific LSF-protein interactions. Other transcription factors participate in mitosis through non-transcriptional means, and we recently reported that LSF directly binds α-tubulin and is present in purified cellular tubulin preparations. Consistent with a microtubule role for LSF, here we show that LSF enhanced the rate of tubulin polymerization in vitro, and FQI1 inhibited such polymerization. To probe whether the FQI1-mediated spindle abnormalities could result from inhibition of mitotic LSF-protein interactions, mass spectrometry was performed using as bait an inducible, tagged form of LSF that is biotinylated by endogenous enzymes. The global proteomics analysis yielded expected associations for a transcription factor, notably with RNA processing machinery, but also to nontranscriptional components. In particular, and consistent with spindle disruption due to FQI treatment, mitotic, FQI1-sensitive interactions were identified between the biotinylated LSF and microtubule-associated proteins that regulate spindle assembly, positioning, and dynamics, as well as centrosome-associated proteins. Probing the mitotic LSF interactome using small molecule inhibitors therefore supported a non-transcriptional role for LSF in mediating progression through mitosis.

Indexed as

Microtubule-Associated ProteinsQuinolonesMicrotubulesMitosisSpindle ApparatusTranscription FactorsTubulinMicrotubule-Associated ProteinsQuinolonesTranscription FactorsTubulin

Identifiers

PMID35704642
PMCPMC9200292
OpenAlexW4282928610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.